| ISSN |
1007-9327 (print) and 2219-2840 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Oncology |
| Manuscript Type |
Retrospective Study |
| Article Title |
Analysis of the clinicopathological characteristics and prognosis of 232 patients with poorly differentiated gastric neuroendocrine neoplasms
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Deng Han, Yuan-Liang Li, Zhi-Wei Zhou, Fei Yin, Jie Chen, Fang Liu, Yan-Fen Shi, Wei Wang, Yu Zhang, Xian-Jun Yu, Jian-Ming Xu, Run-Xiang Yang, Chao Tian, Jie Luo and Huang-Ying Tan |
| ORCID |
|
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| National Key R&D Program of China |
2019YFB1309704 |
|
| Corresponding Author |
Huang-Ying Tan, MD, PhD, Chief Physician, Department of Integrative Oncology, China-Japan Friendship Hospital, No. 2 Yinghuayuan East Street, Chaoyang District, Beijing 100029, China. tanhuangying@263.net |
| Key Words |
Poorly differentiated gastric neuroendocrine neoplasms; Clinicopathological characteristics; Prognosis; Distant metastasis; Tumor diameter |
| Core Tip |
Most patients with poorly differentiated gastric neuroendocrine neoplasms (PDGNENs) presented with lymph node metastasis or distant metastasis at the time of diagnosis, and the 5-year overall survival rate of patients with PDGNENs was only 5%. The malignancy of PDGNENs is very high, and the onset is relatively unclear. Routine gastroscopy may help detect PDGNENs as early as possible. Patients with a tumor diameter > 5 cm, multiple tumors, and with American Joint Committee on Cancer stage III or IV have a poor prognosis. |
| Publish Date |
2021-05-27 09:41 |
| Citation |
Han D, Li YL, Zhou ZW, Yin F, Chen J, Liu F, Shi YF, Wang W, Zhang Y, Yu XJ, Xu JM, Yang RX, Tian C, Luo J, Tan HY. Analysis of the clinicopathological characteristics and prognosis of 232 patients with poorly differentiated gastric neuroendocrine neoplasms. World J Gastroenterol 2021; 27(21): 2895-2909 |
| URL |
https://www.wjgnet.com/1007-9327/full/v27/i21/2895.htm |
| DOI |
https://dx.doi.org/10.3748/wjg.v27.i21.2895 |
